References
- Tayler D B, Bard P. Motion sickness. Physiol Rev 1949; 29: 311–69
- Money K E. Motion sickness. Physiol Rev 1970; 50: 1–30
- Reason J T, Brand JJ. Motion sickness. Academic Press, New York 1975
- Morita M, Takeda N, Hasegawa S. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats. Acta Otolaryngol (Stockh) 1990; 110: 196–202
- Motita M, Takeda N, Kubo T, Matsunaga T. Pica as an index of motion sickness in rats. ORL 1988; 50: 188–92
- McCaffrey RJ. Appropriateness of kaolin consumption as an index of motion sickness in the rat. Physiol Behav 1985; 35: 151–6
- Morita M, Takeda N, Kubo T, Yamatodani A, Wada H, Matsunaga T. Effects of anti-motion sickness drugs on motion sickness in rats. ORL 1988; 50: 330–3
- Wang S C, Borison HL. A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine copper sulfate and cardiac glycosides. Gastroenterology 1952; 22: 1–12
- Borison HL. Area postrema: chemoreceptor circumventricular organ of the medulla oblongata. Prog Neurobiol 1989; 32: 351–90
- Wang S C, Borison HL. Copper sulfate emesis: a study of afferent pathways from the gastrointestinal tract. Am J Physiol 1961; 164: 520–6
- Wang S C, Borison HL. The vomiting center: its destruction by radon implanation in dog medulla oblongata. Am J Physiol 1951; 166: 712–7
- Mehler WR. Observations on the connectivity of the paraventricular reticular formation with respect to vomiting center. Brain Behav Evol 1983; 23: 63–80
- Lucot J B, Crampton GH. Xylazine emesis yohimbine and motion sickness susceptibility in the cat. J Pharmacol Exp Ther 1986; 237: 450–5
- Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 1985; 55: 2766–70
- McCaffrey R J, Graham G. Age-related differences for motion sickness in the rat. Exp Aging Res 1980; 6: 555–61